{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:15:16Z","timestamp":1763640916931},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T00:00:00Z","timestamp":1110240000000},"content-version":"vor","delay-in-days":66,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic factors and the influence of superoxide are known to play roles in the etiology of glaucoma. We evaluated the association between primary open angle glaucoma (POAG) and two polymorphisms in the epithelial nitric oxide synthase (eNOS) gene, and one polymorphism in the myeloperoxidase (MPO) gene. We enrolled 66 patients with POAG and 100 healthy volunteers in this study. The polymorphisms in the eNOS and the polymorphism MPO \u2212463 G\u2010to\u2010A in the MPO gene were resolved by polymorphism polymerase chain reaction (PCR). There were no significant differences in the distribution of the eNOS intron \u22124 (<jats:italic>P=<\/jats:italic>0.481), eNOS promotor \u2212786 (<jats:italic>P<\/jats:italic>=0.555), and MPO \u2212463 (<jats:italic>P<\/jats:italic>=0.292) gene polymorphisms between the POAG patients and the volunteers (<jats:italic>P<\/jats:italic>\u2010values=0.481, 0.555, and 0.292, respectively). None of the alleles from either gene differed between the groups (<jats:italic>P<\/jats:italic>\u2010values=0.483, 0.554, and 0.183, respectively). Superoxide is closely related to glaucoma, and eNOS and MPO are two important enzymes in the free radical pathway. However, polymorphisms of the eNOS intron\u20104, eNOS promotor \u2212786, and MPO \u2212463 gene polymorphisms did not reveal significant differences between POAG patients and controls in our study. The use of these agents and other superoxide\u2010related genes for clinical applications requires further investigation. J. Clin. Lab. Anal. 19:87\u201392, 2005. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jcla.20057","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T15:16:39Z","timestamp":1110294999000},"page":"87-92","source":"Crossref","is-referenced-by-count":13,"title":["Distribution of oxidation enzyme eNOS and myeloperoxidase in primary open angle glaucoma"],"prefix":"10.1002","volume":"19","author":[{"given":"Hui\u2010Ju","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang\u2010Hai","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuu\u2010Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei\u2010Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih\u2010Wei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng\u2010Sheen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713688408997203"},{"key":"e_1_2_1_3_2","first-page":"2967","article-title":"The combined effect of brain\u2010derived neurotrophic factor and a free radical scavenger in experimental glaucoma","volume":"41","author":"Ko ML","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(94)33026-3"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.32.19199"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-09-05147.1994"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.63.070194.001135"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00242-3"},{"key":"e_1_2_1_9_2","first-page":"329","article-title":"Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats","volume":"92","author":"Lam TT","year":"1996","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"e_1_2_1_10_2","first-page":"2396","article-title":"Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats","volume":"36","author":"Ostwald P","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/niox.1997.0133"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.12.7617"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/34923"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0921-8734(92)90030-S"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1998.tb00539.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1999.tb00606.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01041-9"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.32.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(97)84043-X"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0213"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199300230-00011"},{"key":"e_1_2_1_22_2","first-page":"1765","article-title":"Identification of an extensive system of nitric oxide\u2010producing cells in the ciliary muscle and outflow pathway of the human eye","volume":"36","author":"Nathanson JA","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_23_2","first-page":"450","article-title":"Roles of constitutive nitric oxide synthase in postischemic rat retina","volume":"40","author":"Hangai M","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_24_2","first-page":"1774","article-title":"Alterations of ocular nitric oxide synthase in human glaucoma","volume":"36","author":"Nathanson JA","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1179\/016164102101200717"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2000.16.399"},{"key":"e_1_2_1_27_2","first-page":"2540","article-title":"Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit","volume":"38","author":"Oku H","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.20057","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.20057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:53:07Z","timestamp":1700164387000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.20057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1002\/jcla.20057"],"URL":"https:\/\/doi.org\/10.1002\/jcla.20057","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"type":"print","value":"0887-8013"},{"type":"electronic","value":"1098-2825"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}